SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
-9.04%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.19B
AUM Growth
+$1.19B
(-24%)
Cap. Flow
-$79.2M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
66.99%
Holding
79
New
10
Increased
12
Reduced
14
Closed
17
Top Buys
| 1 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$97.8M |
| 2 |
AstraZeneca
AZN
|
$36.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$24.8M |
| 4 |
Zoetis
ZTS
|
$20.1M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$19.7M |
Top Sells
| 1 |
AbbVie
ABBV
|
$42.2M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$26.3M |
| 3 |
Align Technology
ALGN
|
$25.1M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$20.9M |
| 5 |
iRhythm Technologies
IRTC
|
$19.9M |
Sector Composition
| 1 | Healthcare | 98.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INBX
26
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $11.5M | 0.87% | 514,640 +145,961 | +40% | +$3.25M |
|
27
Immatics
IMTX
$619M
| $10.1M | 0.77% | 1,268,063 +241,440 | +24% | +$1.93M |
|
|
JNCE
28
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $10.1M | 0.76% | 1,481,219 -101,558 | -6% | -$690K |
|
|
CTIC
29
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $9.12M | 0.69% | +1,952,691 | New | +$9.12M |
|
30
Adicet Bio
ACET
$59.9M
| $8.31M | 0.63% | 416,289 +105,301 | +34% | +$2.1M |
|
|
INZY
31
DELISTED
Inozyme Pharma
INZY
| $8.3M | 0.63% | 2,028,308 | – | – |
|
32
Bolt Biotherapeutics
BOLT
$9.85M
| $7.55M | 0.57% | 2,754,437 | – | – |
|
|
GRTX
33
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $7.34M | 0.56% | 3,083,712 | – | – |
|
34
Xencor
XNCR
$580M
| $7.31M | 0.55% | 273,992 -263,038 | -49% | -$7.02M |
|
|
AKUS
35
DELISTED
Akouos, Inc. Common Stock
AKUS
| $7.2M | 0.55% | 1,515,074 | – | – |
|
|
BCYC
36
Bicycle Therapeutics
BCYC
$511M
| $7.18M | 0.54% | +163,559 | New | +$7.18M |
|
|
OBSV
37
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $7.17M | 0.54% | 4,749,623 | – | – |
|
38
Sarepta Therapeutics
SRPT
$1.78B
| $6.94M | 0.53% | 88,880 -31,852 | -26% | -$2.49M |
|
|
IMGN
39
DELISTED
Immunogen Inc
IMGN
| $6.8M | 0.52% | 1,428,169 -321,713 | -18% | -$1.53M |
|
|
NCNA
40
NuCana
NCNA
$6.09M
| $5.59M | 0.42% | 5,599,999 | – | – |
|
41
Fulcrum Therapeutics
FULC
$351M
| $5.43M | 0.41% | 229,509 -388,161 | -63% | -$9.18M |
|
42
Geron
GERN
$893M
| $2.59M | 0.2% | +1,904,762 | New | +$2.59M |
|
43
Pfizer
PFE
$141B
| $2.56M | 0.19% | +49,378 | New | +$2.56M |
|
44
Cytokinetics
CYTK
$4.23B
| $2.32M | 0.18% | 62,944 -401,422 | -86% | -$14.8M |
|
45
Synlogic
SYBX
$17M
| $1.38M | 0.1% | 574,972 | – | – |
|
46
Amylyx Pharmaceuticals
AMLX
$836M
| $1.29M | 0.1% | +100,000 | New | +$1.29M |
|
47
PDS Biotechnology
PDSB
$57.8M
| $883K | 0.07% | 142,635 | – | – |
|
48
MiNK Therapeutics
INKT
$64.4M
| $745K | 0.06% | 331,002 -14,497 | -4% | -$32.6K |
|
|
FUSN
49
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $607K | 0.05% | 78,066 | – | – |
|
50
Insulet
PODD
$23.9B
| $284K | 0.02% | 1,066 | – | – |
|